LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 55

Search options

  1. Article ; Online: Pathogen clearance and immune adherence "revisited": Immuno-regulatory roles for CRIg.

    van Lookeren Campagne, Menno / Verschoor, Admar

    Seminars in immunology

    2018  Volume 37, Page(s) 4–11

    Abstract: Rapid elimination of microbes from the bloodstream, along with the ability to mount an adaptive immune response, are essential for optimal host-defense. Kupffer cells are strategically positioned in the liver sinusoids and efficiently capture circulating ...

    Abstract Rapid elimination of microbes from the bloodstream, along with the ability to mount an adaptive immune response, are essential for optimal host-defense. Kupffer cells are strategically positioned in the liver sinusoids and efficiently capture circulating microbes from the hepatic artery and portal vein, thus preventing bacterial dissemination. In vivo and in vitro studies have probed how complement receptor of the immunoglobulin superfamily (CRIg), also referred to as Z39Ig and V-set and Ig domain-containing 4 (VSIG4), acts as a critical player in pathogen recognition and clearance. While recent data suggested that CRIg may bind bacterial cell wall components directly, the single transmembrane receptor is best known for its interaction with complement C3 opsonization products on the microbial surface. On Kupffer cells, CRIg must capture opsonized microbes against the shear forces of the blood flow. In vivo work reveals how immune adherence (IA), a process in which blood platelets or erythrocytes associate with circulating bacteria, plays a critical role in regulating pathogen capture by CRIg under flow conditions. In addition to its typical innate immune functions, CRIg was shown to directly and indirectly influence adaptive immune responses. Here, we review our current understanding of the diverse roles of CRIg in pathogen elimination, anti-microbial immunity and autoimmunity. In particular, we will explore how, through selective capturing by CRIg, an important balance is achieved between the immunological and clearance functions of liver and spleen.
    MeSH term(s) Agglutination ; Animals ; Bacterial Infections/immunology ; Complement C3/metabolism ; Host-Pathogen Interactions ; Humans ; Immunomodulation ; Kupffer Cells/physiology ; Opsonin Proteins/metabolism ; Pathogen-Associated Molecular Pattern Molecules/immunology ; Receptors, Complement/metabolism ; Receptors, Pattern Recognition/metabolism
    Chemical Substances Complement C3 ; Opsonin Proteins ; Pathogen-Associated Molecular Pattern Molecules ; Receptors, Complement ; Receptors, Pattern Recognition ; VSIG4 protein, human
    Language English
    Publishing date 2018-03-21
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1018141-6
    ISSN 1096-3618 ; 1044-5323
    ISSN (online) 1096-3618
    ISSN 1044-5323
    DOI 10.1016/j.smim.2018.02.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Humoral immunity goes hormonal.

    Chavarria-Smith, Joseph / Hazenbos, Wouter L W / van Lookeren Campagne, Menno

    Nature immunology

    2018  Volume 19, Issue 10, Page(s) 1044–1046

    MeSH term(s) Antibodies ; Enteropathogenic Escherichia coli ; Female ; Humans ; Immunity, Humoral ; Infant
    Chemical Substances Antibodies
    Language English
    Publishing date 2018-09-19
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2016987-5
    ISSN 1529-2916 ; 1529-2908
    ISSN (online) 1529-2916
    ISSN 1529-2908
    DOI 10.1038/s41590-018-0216-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: An ancient mechanism of arginine-specific substrate cleavage: What's 'up' with NSP4?

    AhYoung, Andrew P / Lin, S Jack / Gerhardy, Stefan / van Lookeren Campagne, Menno / Kirchhofer, Daniel

    Biochimie

    2019  Volume 166, Page(s) 19–26

    Abstract: The recently discovered neutrophil serine protease 4 (NSP4) is the fourth member of the NSP family, which includes the well-studied neutrophil elastase, proteinase 3 and cathepsin G. Like the other three NSP members, NSP4 is synthesized by myeloid ... ...

    Abstract The recently discovered neutrophil serine protease 4 (NSP4) is the fourth member of the NSP family, which includes the well-studied neutrophil elastase, proteinase 3 and cathepsin G. Like the other three NSP members, NSP4 is synthesized by myeloid precursors in the bone marrow and, after cleavage of the two-amino acid activation peptide, is stored as an active protease in azurophil granules of neutrophils. Based on its primary amino acid sequence, NSP4 is predicted to have a shallow S1 specificity pocket with elastase-like substrate specificity. However, NSP4 was found to preferentially cleave after an arginine residue. Structural studies resolved this paradox by revealing an unprecedented mechanism of P1-arginine recognition. In contrast to the canonical mechanism in which the P1-arginine residue points down into a deep S1 pocket, the arginine side chain adopts a surface-exposed 'up' conformation in the NSP4 active site. This conformation is stabilized by the Phe190 residue, which serves as a hydrophobic platform for the aliphatic portion of the arginine side chain, and a network of hydrogen bonds between the arginine guanidium group and the NSP4 residues Ser192 and Ser216. This unique configuration allows NSP4 to cleave even after naturally modified arginine residues, such as citrulline and methylarginine. This non-canonical mechanism, characterized by the hallmark 'triad' Phe190-Ser192-Ser216, is largely preserved throughout evolution starting with bony fish, which appeared about 400 million years ago. Although the substrates and physiological role of NSP4 remain to be determined, its remarkable evolutionary conservation, restricted tissue expression and homology to other neutrophil serine proteases anticipate a function in immune-related processes.
    MeSH term(s) Animals ; Arginine/chemistry ; Catalytic Domain ; Humans ; Kinetics ; Mice ; Neutrophils/enzymology ; Proteolysis ; Serine Endopeptidases/chemistry ; Substrate Specificity
    Chemical Substances Arginine (94ZLA3W45F) ; Serine Endopeptidases (EC 3.4.21.-)
    Language English
    Publishing date 2019-04-01
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 120345-9
    ISSN 1638-6183 ; 0300-9084
    ISSN (online) 1638-6183
    ISSN 0300-9084
    DOI 10.1016/j.biochi.2019.03.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: An ancient mechanism of arginine-specific substrate cleavage: What's ‘up’ with NSP4?

    AhYoung, Andrew P / Gerhardy, Stefan / Kirchhofer, Daniel / Lin, S. Jack / van Lookeren Campagne, Menno

    Biochimie. 2019 Nov., v. 166

    2019  

    Abstract: The recently discovered neutrophil serine protease 4 (NSP4) is the fourth member of the NSP family, which includes the well-studied neutrophil elastase, proteinase 3 and cathepsin G. Like the other three NSP members, NSP4 is synthesized by myeloid ... ...

    Abstract The recently discovered neutrophil serine protease 4 (NSP4) is the fourth member of the NSP family, which includes the well-studied neutrophil elastase, proteinase 3 and cathepsin G. Like the other three NSP members, NSP4 is synthesized by myeloid precursors in the bone marrow and, after cleavage of the two-amino acid activation peptide, is stored as an active protease in azurophil granules of neutrophils. Based on its primary amino acid sequence, NSP4 is predicted to have a shallow S1 specificity pocket with elastase-like substrate specificity. However, NSP4 was found to preferentially cleave after an arginine residue. Structural studies resolved this paradox by revealing an unprecedented mechanism of P1-arginine recognition. In contrast to the canonical mechanism in which the P1-arginine residue points down into a deep S1 pocket, the arginine side chain adopts a surface-exposed ‘up’ conformation in the NSP4 active site. This conformation is stabilized by the Phe190 residue, which serves as a hydrophobic platform for the aliphatic portion of the arginine side chain, and a network of hydrogen bonds between the arginine guanidium group and the NSP4 residues Ser192 and Ser216. This unique configuration allows NSP4 to cleave even after naturally modified arginine residues, such as citrulline and methylarginine. This non-canonical mechanism, characterized by the hallmark ‘triad’ Phe190-Ser192-Ser216, is largely preserved throughout evolution starting with bony fish, which appeared about 400 million years ago. Although the substrates and physiological role of NSP4 remain to be determined, its remarkable evolutionary conservation, restricted tissue expression and homology to other neutrophil serine proteases anticipate a function in immune-related processes.
    Keywords active sites ; amino acid sequences ; arginine ; bone marrow ; cathepsin G ; citrulline ; elastase ; evolution ; fish ; hydrogen bonding ; hydrophobicity ; neutrophils ; peptides ; substrate specificity
    Language English
    Dates of publication 2019-11
    Size p. 19-26.
    Publishing place Elsevier B.V.
    Document type Article
    ZDB-ID 120345-9
    ISSN 0300-9084
    ISSN 0300-9084
    DOI 10.1016/j.biochi.2019.03.020
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Age-related macular degeneration: Complement in action.

    van Lookeren Campagne, Menno / Strauss, Erich C / Yaspan, Brian L

    Immunobiology

    2016  Volume 221, Issue 6, Page(s) 733–739

    Abstract: The complement system plays a key role in host-defense against common pathogens but must be tightly controlled to avoid inflammation and tissue damage. Polymorphisms in genes encoding two important negative regulators of the alternative complement ... ...

    Abstract The complement system plays a key role in host-defense against common pathogens but must be tightly controlled to avoid inflammation and tissue damage. Polymorphisms in genes encoding two important negative regulators of the alternative complement pathway, complement factor H (CFH) and complement factor I (CFI), are associated with the risk for Age-Related Macular Degeneration (AMD), a leading cause of vision impairment in the ageing population. In this review, we will discuss the genetic basis of AMD and the potential impact of complement de-regulation on disease pathogenesis. Finally, we will highlight recent therapeutic approaches aimed at controlling complement activation in patients with AMD.
    Language English
    Publishing date 2016
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 563292-4
    ISSN 1878-3279 ; 0171-2985
    ISSN (online) 1878-3279
    ISSN 0171-2985
    DOI 10.1016/j.imbio.2015.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Understanding Crohn's disease through genetics.

    Murthy, Aditya / van Lookeren Campagne, Menno

    Cell cycle (Georgetown, Tex.)

    2014  Volume 13, Issue 18, Page(s) 2803–2804

    MeSH term(s) Animals ; Carrier Proteins/genetics ; Carrier Proteins/metabolism ; Caspase 3/metabolism ; Crohn Disease/genetics ; Female ; Humans ; Male ; Polymorphism, Single Nucleotide/genetics ; Proteolysis
    Chemical Substances Carrier Proteins ; Caspase 3 (EC 3.4.22.-)
    Language English
    Publishing date 2014-12-18
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2146183-1
    ISSN 1551-4005 ; 1538-4101 ; 1554-8627
    ISSN (online) 1551-4005
    ISSN 1538-4101 ; 1554-8627
    DOI 10.4161/15384101.2014.959851
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Integration of eQTL and a Single-Cell Atlas in the Human Eye Identifies Causal Genes for Age-Related Macular Degeneration.

    Orozco, Luz D / Chen, Hsu-Hsin / Cox, Christian / Katschke, Kenneth J / Rommel Arceo / Espiritu, Carmina / Caplazi, Patrick / Nghiem, Sarajane Saturnio / Chen, Ying-Jiun / Modrusan, Zora / Dressen, Amy / Goldstein, Leonard D / Clarke, Christine / Bhangale, Tushar / Yaspan, Brian / Jeanne, Marion / Townsend, Michael J / van Lookeren Campagne, Menno / Hackney, Jason A

    Cell reports

    2023  Volume 42, Issue 3, Page(s) 112298

    Language English
    Publishing date 2023-03-22
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2023.112298
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.

    Boyer, David S / Schmidt-Erfurth, Ursula / van Lookeren Campagne, Menno / Henry, Erin C / Brittain, Christopher

    Retina (Philadelphia, Pa.)

    2017  Volume 37, Issue 5, Page(s) 819–835

    Abstract: Purpose: Geographic atrophy (GA) is an advanced, vision-threatening form of age-related macular degeneration (AMD) affecting approximately five million individuals worldwide. To date, there are no approved therapeutics for GA treatment; however, several ...

    Abstract Purpose: Geographic atrophy (GA) is an advanced, vision-threatening form of age-related macular degeneration (AMD) affecting approximately five million individuals worldwide. To date, there are no approved therapeutics for GA treatment; however, several are in clinical trials. This review focuses on the pathophysiology of GA, particularly the role of complement cascade dysregulation and emerging therapies targeting the complement cascade.
    Methods: Primary literature search on PubMed for GA, complement cascade in age-related macular degeneration. ClinicalTrials.gov was searched for natural history studies in GA and clinical trials of drugs targeting the complement cascade for GA.
    Results: Cumulative damage to the retina by aging, environmental stress, and other factors triggers inflammation via multiple pathways, including the complement cascade. When regulatory components in these pathways are compromised, as with several GA-linked genetic risk factors in the complement cascade, chronic inflammation can ultimately lead to the retinal cell death characteristic of GA. Complement inhibition has been identified as a key candidate for therapeutic intervention, and drugs targeting the complement pathway are currently in clinical trials.
    Conclusion: The complement cascade is a strategic target for GA therapy. Further research, including on natural history and genetics, is crucial to expand the understanding of GA pathophysiology and identify effective therapeutic targets.
    MeSH term(s) Aging ; Antibodies, Monoclonal, Humanized/therapeutic use ; Clinical Trials as Topic ; Complement System Proteins/physiology ; Environment ; Geographic Atrophy/drug therapy ; Geographic Atrophy/etiology ; Geographic Atrophy/physiopathology ; Humans ; Macular Degeneration/complications ; Molecular Targeted Therapy/methods
    Chemical Substances Antibodies, Monoclonal, Humanized ; Complement System Proteins (9007-36-7)
    Language English
    Publishing date 2017-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 603192-4
    ISSN 1539-2864 ; 0275-004X
    ISSN (online) 1539-2864
    ISSN 0275-004X
    DOI 10.1097/IAE.0000000000001392
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Immunology: In command of commensals.

    van Lookeren Campagne, Menno / Dixit, Vishva M

    Nature

    2011  Volume 474, Issue 7349, Page(s) 42–43

    MeSH term(s) Animals ; Epithelial Cells/immunology ; Epithelial Cells/microbiology ; Host-Pathogen Interactions/immunology ; Humans ; Inflammasomes/immunology ; Inflammatory Bowel Diseases/immunology ; Intestinal Mucosa/immunology ; Intracellular Signaling Peptides and Proteins/metabolism
    Chemical Substances Inflammasomes ; Intracellular Signaling Peptides and Proteins ; NLRP6 protein, human
    Language English
    Publishing date 2011-06-02
    Publishing country England
    Document type News
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/474042a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development.

    Mai, Elaine / Chan, Joyce / Goon, Levina / Ego, Braeden K / Bevers, Jack / Wong, Tiffany / Wong, Manda / Corpuz, Racquel / Xi, Hongkang / Wu, Jia / Schneider, Kellen / Seshasayee, Dhaya / Grimbaldeston, Michele / Nakamura, Gerald / Indjeian, Vahan B / van Lookeren Campagne, Menno / Loyet, Kelly M / Comps-Agrar, Laetitia

    Journal of translational medicine

    2021  Volume 19, Issue 1, Page(s) 517

    Abstract: Background: Over the past decade, human Interleukin 33 (hIL-33) has emerged as a key contributor to the pathogenesis of numerous inflammatory diseases. Despite the existence of several commercial hIL-33 assays spanning multiple platform technologies, ... ...

    Abstract Background: Over the past decade, human Interleukin 33 (hIL-33) has emerged as a key contributor to the pathogenesis of numerous inflammatory diseases. Despite the existence of several commercial hIL-33 assays spanning multiple platform technologies, their ability to provide accurate hIL-33 concentration measurements and to differentiate between active (reduced) and inactive (oxidized) hIL-33 in various matrices remains uncertain. This is especially true for lower sample volumes, matrices with low hIL-33 concentrations, and matrices with elevated levels of soluble Interleukin 1 Receptor-Like 1 (sST2), an inactive form of ST2 that competes with membrane bound ST2 for hIL-33 binding.
    Results: We tested the performance of several commercially available hIL-33 detection assays in various human matrices and found that most of these assays lacked the sensitivity to accurately detect reduced hIL-33 at biologically relevant levels (sub-to-low pg/mL), especially in the presence of human sST2 (hsST2), and/or lacked sufficient target specificity. To address this, we developed and validated a sensitive and specific enzyme-linked immunosorbent assay (ELISA) capable of detecting reduced and total hIL-33 levels even in the presence of high concentrations of sST2. By incorporating the immuno-polymerase chain reaction (iPCR) platform, we further increased the sensitivity of this assay for the reduced form of hIL-33 by ~ 52-fold. Using this hIL-33 iPCR assay, we detected hIL-33 in postmortem human vitreous humor (VH) samples from donors with age-related macular degeneration (AMD) and found significantly increased hIL-33 levels when compared to control individuals. No statistically significant difference was observed in aqueous humor (AH) from AMD donors nor in plasma and nasosorption fluid (NF) from asthma patients compared to control individuals.
    Conclusions: Unlike existing commercial hIL-33 assays, our hIL-33 bioassays are highly sensitive and specific and can accurately quantify hIL-33 in various human clinical matrices, including those with high levels of hsST2. Our results provide a proof of concept of the utility of these assays in clinical trials targeting the hIL-33/hST2 pathway.
    MeSH term(s) Asthma ; Biological Assay ; Biomarkers ; Drug Development ; Enzyme-Linked Immunosorbent Assay/methods ; Humans ; Interleukin-33 ; Macular Degeneration ; Sensitivity and Specificity
    Chemical Substances Biomarkers ; Interleukin-33
    Language English
    Publishing date 2021-12-20
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2118570-0
    ISSN 1479-5876 ; 1479-5876
    ISSN (online) 1479-5876
    ISSN 1479-5876
    DOI 10.1186/s12967-021-03189-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top